Header Logo

Sarju Ganatra

Concepts (274)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
24
2025
1231
4.100
Why?
Cardiovascular Diseases
17
2025
788
3.160
Why?
Myocarditis
14
2024
60
2.590
Why?
Cardiotoxicity
9
2025
15
2.070
Why?
Immunotherapy
4
2025
228
1.900
Why?
Heart Failure
9
2024
853
1.850
Why?
Diabetes Mellitus, Type 2
5
2025
635
1.830
Why?
Cardiomyopathies
5
2024
119
1.780
Why?
Atrial Fibrillation
6
2024
805
1.550
Why?
Antineoplastic Agents
6
2023
628
1.510
Why?
Percutaneous Coronary Intervention
5
2024
160
1.460
Why?
Coronary Artery Disease
3
2024
274
1.360
Why?
Stroke Volume
8
2024
314
1.360
Why?
Intracranial Hemorrhages
2
2021
61
1.240
Why?
Humans
80
2025
59366
1.180
Why?
Climate Change
3
2025
18
1.100
Why?
Ritonavir
3
2023
17
1.090
Why?
Immunotherapy, Adoptive
3
2024
87
1.050
Why?
Cardiology
5
2024
163
1.020
Why?
Medical Oncology
7
2024
57
1.010
Why?
Catheter Ablation
2
2024
145
0.950
Why?
Water Pollutants, Chemical
1
2025
35
0.950
Why?
Glucagon-Like Peptide-1 Receptor
1
2024
19
0.930
Why?
Perioperative Care
1
2025
76
0.900
Why?
Environmental Exposure
2
2025
209
0.890
Why?
Heart Diseases
3
2022
206
0.880
Why?
Stroke
2
2024
1127
0.860
Why?
Nervous System Diseases
1
2025
104
0.860
Why?
Cardiovascular Agents
2
2022
98
0.790
Why?
Overweight
1
2024
238
0.780
Why?
Aged
27
2025
13405
0.740
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2023
204
0.730
Why?
Septal Occluder Device
1
2021
11
0.730
Why?
Risk Factors
17
2025
4986
0.730
Why?
Cardiac Surgical Procedures
2
2023
249
0.720
Why?
Cross Infection
2
2020
149
0.700
Why?
Atrial Appendage
1
2021
29
0.700
Why?
Lymphoma, Non-Hodgkin
1
2020
50
0.690
Why?
Cell- and Tissue-Based Therapy
1
2020
38
0.690
Why?
Drug-Eluting Stents
2
2017
52
0.690
Why?
Cardiovascular System
1
2020
38
0.680
Why?
Venous Thrombosis
2
2018
110
0.670
Why?
Hypertension
2
2025
568
0.650
Why?
Retrospective Studies
17
2025
6069
0.640
Why?
Middle Aged
23
2025
16310
0.630
Why?
Heart Function Tests
1
2018
14
0.620
Why?
Female
32
2025
30719
0.620
Why?
Medical Overuse
1
2018
9
0.620
Why?
Air Microbiology
1
2018
8
0.620
Why?
Nontuberculous Mycobacteria
1
2018
7
0.620
Why?
Heating
1
2018
8
0.620
Why?
Equipment Contamination
1
2018
31
0.610
Why?
Mycobacterium Infections, Nontuberculous
1
2018
14
0.610
Why?
Immunity, Cellular
1
2019
171
0.610
Why?
Delivery of Health Care
1
2022
411
0.600
Why?
Betacoronavirus
1
2020
166
0.600
Why?
Sarcoidosis
1
2018
30
0.590
Why?
Iliac Vein
1
2018
9
0.590
Why?
Pyrazoles
1
2018
65
0.590
Why?
Registries
7
2024
799
0.580
Why?
Pyrimidines
1
2018
131
0.570
Why?
Arrhythmogenic Right Ventricular Dysplasia
1
2017
13
0.550
Why?
Coronavirus Infections
1
2020
192
0.550
Why?
Vascular Access Devices
1
2017
15
0.550
Why?
Pneumonia, Viral
1
2020
205
0.550
Why?
Stents
2
2017
461
0.540
Why?
Obesity
1
2024
1166
0.530
Why?
Heart Valve Prosthesis Implantation
1
2018
153
0.520
Why?
Male
29
2025
27742
0.520
Why?
Tissue Plasminogen Activator
1
2017
125
0.510
Why?
Fibrinolytic Agents
1
2017
163
0.500
Why?
Pharmacovigilance
3
2024
13
0.500
Why?
Thrombolytic Therapy
1
2017
184
0.500
Why?
Treatment Outcome
10
2024
5281
0.490
Why?
Quality of Life
1
2022
1137
0.480
Why?
Adult
16
2025
15679
0.470
Why?
Pulmonary Embolism
1
2017
169
0.470
Why?
Adverse Drug Reaction Reporting Systems
3
2024
45
0.470
Why?
Ventricular Function, Left
5
2024
257
0.470
Why?
Risk Assessment
8
2025
1925
0.460
Why?
Aged, 80 and over
12
2025
5119
0.450
Why?
United States
14
2025
7426
0.440
Why?
Endovascular Procedures
2
2017
608
0.430
Why?
Renal Insufficiency, Chronic
2
2025
114
0.430
Why?
Cardiologists
2
2023
26
0.420
Why?
Air Pollution
2
2023
29
0.420
Why?
Death, Sudden, Cardiac
1
2017
349
0.420
Why?
Electrocardiography
4
2021
521
0.410
Why?
United States Food and Drug Administration
2
2024
85
0.400
Why?
Pandemics
5
2023
616
0.370
Why?
Angioedema
2
2021
10
0.360
Why?
Myocardial Infarction
3
2023
861
0.340
Why?
Acute Coronary Syndrome
2
2023
250
0.330
Why?
Breast Neoplasms
3
2024
1118
0.320
Why?
Anthracyclines
3
2023
10
0.300
Why?
Heart Rate
2
2021
307
0.300
Why?
Antineoplastic Agents, Immunological
2
2019
41
0.290
Why?
Hospitalization
6
2024
1290
0.290
Why?
Cardiac Catheterization
2
2021
253
0.280
Why?
Databases, Factual
3
2025
814
0.270
Why?
Young Adult
6
2024
4273
0.270
Why?
Observational Studies as Topic
2
2023
55
0.260
Why?
Randomized Controlled Trials as Topic
3
2024
677
0.250
Why?
Hypoglycemic Agents
2
2024
192
0.250
Why?
Echocardiography
2
2020
457
0.250
Why?
Incidence
4
2024
1238
0.240
Why?
Mobility Limitation
1
2025
47
0.240
Why?
Predictive Value of Tests
4
2022
1027
0.240
Why?
Drug-Related Side Effects and Adverse Reactions
2
2024
140
0.230
Why?
Prevalence
2
2025
1253
0.230
Why?
Adolescent
6
2024
5835
0.230
Why?
Stenosis, Pulmonary Vein
1
2024
3
0.230
Why?
Bayes Theorem
1
2024
109
0.220
Why?
Metabolic Syndrome
1
2025
131
0.220
Why?
Cross-Sectional Studies
3
2025
2380
0.220
Why?
Sodium-Glucose Transporter 2
1
2023
6
0.220
Why?
Nutrition Surveys
1
2024
130
0.220
Why?
Amyloidosis
1
2024
62
0.210
Why?
Propensity Score
1
2024
144
0.210
Why?
Antibiotics, Antineoplastic
1
2023
31
0.210
Why?
Amyloid Neuropathies, Familial
1
2023
16
0.210
Why?
Anti-Arrhythmia Agents
1
2023
96
0.200
Why?
Drug Interactions
1
2022
115
0.200
Why?
Heart Valve Diseases
1
2023
88
0.200
Why?
Air Pollutants
1
2023
76
0.200
Why?
Transcatheter Aortic Valve Replacement
1
2024
96
0.200
Why?
Vinca Alkaloids
1
2021
1
0.190
Why?
Taxoids
1
2021
24
0.190
Why?
Heart
3
2021
274
0.190
Why?
Neoplasm Recurrence, Local
1
2023
300
0.190
Why?
Aortic Valve Stenosis
1
2024
170
0.190
Why?
Hyperkalemia
1
2021
19
0.180
Why?
Angiotensin II
1
2021
23
0.180
Why?
Shock
1
2021
31
0.180
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
39
0.180
Why?
Giant Cells
1
2021
15
0.180
Why?
Medicare
2
2023
601
0.180
Why?
Hypotension
1
2021
48
0.180
Why?
Drug Administration Schedule
2
2020
284
0.180
Why?
Vasoconstrictor Agents
1
2021
64
0.180
Why?
Heart Conduction System
1
2021
50
0.180
Why?
Bundle-Branch Block
1
2020
14
0.180
Why?
Biopsy
2
2021
410
0.180
Why?
Action Potentials
1
2021
101
0.180
Why?
Tachycardia, Ventricular
1
2022
119
0.170
Why?
Rural Population
1
2022
188
0.170
Why?
Health Care Costs
1
2022
202
0.170
Why?
Platelet Aggregation Inhibitors
2
2023
211
0.170
Why?
Multimodal Imaging
1
2020
64
0.170
Why?
Heart Arrest
1
2022
161
0.170
Why?
Kidney Diseases
1
2021
169
0.160
Why?
Atherosclerosis
1
2021
146
0.160
Why?
Asthma
1
2023
457
0.160
Why?
Dementia
1
2022
248
0.160
Why?
Acute Kidney Injury
1
2020
132
0.150
Why?
Adrenal Cortex Hormones
1
2020
168
0.150
Why?
Diagnosis, Differential
2
2018
931
0.150
Why?
Physical Examination
1
2018
104
0.150
Why?
Lymphoma, B-Cell
1
2018
59
0.150
Why?
Global Health
1
2019
167
0.150
Why?
Piperidines
1
2018
55
0.150
Why?
Adenine
1
2018
49
0.150
Why?
Operating Rooms
1
2018
55
0.150
Why?
Influenza Vaccines
1
2019
91
0.140
Why?
Comorbidity
2
2019
1078
0.140
Why?
Time Factors
3
2024
3615
0.140
Why?
Anticoagulants
2
2022
480
0.140
Why?
Cardiomyopathy, Hypertrophic
2
2024
753
0.140
Why?
Interdisciplinary Communication
1
2018
103
0.140
Why?
Hypothyroidism
1
2017
39
0.140
Why?
Foreign-Body Migration
1
2017
20
0.140
Why?
Drug Therapy, Combination
1
2018
451
0.140
Why?
Pulmonary Disease, Chronic Obstructive
1
2023
657
0.140
Why?
Attitude
1
2017
96
0.140
Why?
Fatal Outcome
1
2017
116
0.140
Why?
Prosthesis Design
1
2017
209
0.140
Why?
Device Removal
1
2017
64
0.130
Why?
Clinical Trials as Topic
1
2019
440
0.130
Why?
Clinical Decision-Making
1
2017
147
0.130
Why?
Influenza, Human
1
2019
192
0.130
Why?
Computed Tomography Angiography
1
2017
110
0.130
Why?
Lyme Disease
1
2017
104
0.130
Why?
Ultrasonography, Interventional
1
2017
92
0.130
Why?
Equipment Design
1
2017
329
0.130
Why?
Lower Extremity
1
2017
152
0.120
Why?
Patient Selection
1
2017
465
0.120
Why?
Length of Stay
3
2023
776
0.120
Why?
Curriculum
1
2018
558
0.110
Why?
Anti-Bacterial Agents
1
2018
734
0.100
Why?
Magnetic Resonance Imaging
1
2021
2052
0.100
Why?
Valsartan
2
2021
12
0.090
Why?
Aminobutyrates
2
2021
10
0.090
Why?
Trastuzumab
2
2021
11
0.090
Why?
Tetrazoles
2
2021
21
0.090
Why?
Biphenyl Compounds
2
2021
31
0.090
Why?
Drug Combinations
2
2021
147
0.090
Why?
Troponin T
2
2022
23
0.090
Why?
Angiotensin Receptor Antagonists
2
2021
64
0.090
Why?
Inpatients
2
2023
291
0.080
Why?
Hospitals
2
2022
377
0.080
Why?
Algorithms
2
2024
974
0.070
Why?
Hospital Mortality
2
2022
841
0.070
Why?
Case-Control Studies
2
2018
1051
0.060
Why?
Prospective Studies
2
2024
3067
0.060
Why?
Dyslipidemias
1
2025
33
0.060
Why?
Canagliflozin
1
2024
5
0.060
Why?
Pericarditis
1
2024
8
0.060
Why?
Glucosides
1
2024
13
0.060
Why?
Natural Language Processing
1
2024
47
0.050
Why?
Child
2
2024
4187
0.050
Why?
Meta-Analysis as Topic
1
2024
77
0.050
Why?
Benzhydryl Compounds
1
2024
48
0.050
Why?
Cause of Death
1
2024
210
0.050
Why?
Environmental Pollution
1
2023
12
0.050
Why?
Multicenter Studies as Topic
1
2023
130
0.050
Why?
Prealbumin
1
2023
19
0.050
Why?
Prasugrel Hydrochloride
1
2023
12
0.050
Why?
Purinergic P2Y Receptor Antagonists
1
2023
13
0.050
Why?
Adenosine Diphosphate
1
2023
40
0.050
Why?
Mortality
1
2024
155
0.050
Why?
Mitral Valve
1
2023
105
0.050
Why?
Aortic Valve
1
2024
173
0.050
Why?
Hemorrhage
1
2024
260
0.050
Why?
Social Determinants of Health
1
2024
122
0.050
Why?
Societies, Medical
1
2024
337
0.050
Why?
Sex Characteristics
1
2023
197
0.050
Why?
Coronary Artery Bypass
1
2023
275
0.050
Why?
Electric Countershock
1
2022
99
0.050
Why?
Arrhythmias, Cardiac
1
2022
145
0.050
Why?
Arterial Pressure
1
2021
22
0.050
Why?
Endocardium
1
2021
12
0.050
Why?
Cardiac Imaging Techniques
1
2021
17
0.050
Why?
Electronic Health Records
1
2024
342
0.050
Why?
Troponin I
1
2021
34
0.050
Why?
Natriuretic Peptide, Brain
1
2021
52
0.040
Why?
Niacinamide
1
2020
32
0.040
Why?
Antiviral Agents
1
2023
313
0.040
Why?
Proteasome Inhibitors
1
2020
30
0.040
Why?
Phenotype
1
2024
1137
0.040
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2021
142
0.040
Why?
Receptor, ErbB-2
1
2020
49
0.040
Why?
Oxygen
1
2022
313
0.040
Why?
Radiotherapy
1
2020
61
0.040
Why?
Artificial Intelligence
1
2022
154
0.040
Why?
Heart Transplantation
1
2021
162
0.040
Why?
Gadolinium
1
2020
103
0.040
Why?
Protein Kinase Inhibitors
1
2020
170
0.040
Why?
Renal Dialysis
1
2020
189
0.040
Why?
Magnetic Resonance Imaging, Cine
1
2020
107
0.040
Why?
Magnetic Resonance Spectroscopy
1
2020
292
0.040
Why?
Patient Readmission
1
2023
420
0.040
Why?
Survivorship
1
2018
12
0.040
Why?
Heart-Assist Devices
1
2021
129
0.040
Why?
Immunosuppressive Agents
1
2021
365
0.040
Why?
Dose-Response Relationship, Drug
1
2020
805
0.040
Why?
Interprofessional Relations
1
2019
129
0.040
Why?
Methylprednisolone
1
2018
32
0.040
Why?
Program Development
1
2019
203
0.040
Why?
Cohort Studies
1
2023
2375
0.040
Why?
Defibrillators, Implantable
1
2021
257
0.040
Why?
Contrast Media
1
2020
400
0.040
Why?
T-Lymphocytes
1
2022
986
0.040
Why?
Exercise Test
1
2018
242
0.030
Why?
Referral and Consultation
1
2020
405
0.030
Why?
Child, Preschool
1
2022
1792
0.030
Why?
Program Evaluation
1
2019
470
0.030
Why?
Echocardiography, Transesophageal
1
2017
92
0.030
Why?
Glucocorticoids
1
2018
179
0.030
Why?
Vaccination
1
2019
337
0.030
Why?
Melanoma
1
2020
318
0.030
Why?
Biomarkers
1
2021
1306
0.030
Why?
Follow-Up Studies
1
2020
2338
0.030
Why?
Lung Neoplasms
1
2020
584
0.030
Why?
Tomography, X-Ray Computed
1
2017
1507
0.020
Why?
Ganatra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (274)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_